Photo

Photo detail

Larry Kwak

Stories this photo appears in:

PeproMene Bio Receives $40 Million

Biotech firm’s immunotherapy drug was developed at City of Hope

PeproMene Bio Inc., an Irvine-based biotechnology company with a blood cancer immunotherapy licensed from City of Hope, has received $40.2 million in investor funding.

Tease photo